Stocks
Lonza Group AGLZAGY
OTCHealthcareLife Sciences Tools & Services$60.69-1.81%
A Swiss life sciences company that provides contract development and manufacturing services to pharmaceutical and biotechnology firms, helping bring biologic drugs, cell and gene therapies, and small‑molecule medicines to market. The business also produces specialty ingredients and capsules used in ...
Market Cap: $43.2B52W Range: $55.57 – $73.85
Congressional Interest in Lonza Group AG (LZAGY)
6 members of Congress have disclosed 14 trades in Lonza Group AG (LZAGY), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 9 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
14
Unique Politicians
6
Buys
5
Sells
9
Who in Congress Is Trading LZAGY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-12-21 | Josh Gottheimer | sell | $1K – $15K |
| 2023-12-05 | Josh Gottheimer | sell | $1K – $15K |